HHS Logo U.S. Department of Health & Human Services Divider arrow NIH logo National Institutes of Health Alt desc
Skip Over Navigation Links
News and Events

CTSA Program Funding Opportunity Now Available

On Sept. 12, 2014, NCATS released a new funding opportunity for the Clinical and Translational Science Awards (CTSA) program, a national network of medical research institutions collaborating to transform how clinical and translational science is conducted nationwide. Applications are due Jan. 15, 2015.

 CTSA hubs — the medical research centers that make up the CTSA network — support high-quality clinical and translational research locally, regionally and nationally, fostering innovation in training, collaboration and new methodologies. NCATS is continuing to develop the CTSA program to meet the evolving needs of clinical and translational investigators and the communities they serve.

 “The CTSA program is a unique national resource through which we have the capability to transform the translational landscape to get more treatments to more patients more quickly,” said NCATS Director Christopher P. Austin, M.D. “This new funding opportunity represents a key step in addressing the national need for resources and support to improve and accelerate translation.”

 For this latest opportunity, NCATS considered the Institute of Medicine findings on the CTSA program and a subsequent NCATS Advisory Council Working Group report (PDF - 414KB) in response to the IOM’s findings, as well as input from CTSA principal investigators and others in the broader research community. There is new emphasis on:                 

  • Aligning the CTSA program more directly with NCATS’ overall goals;
  • Building a collaborative, national network to achieve strategic translational science goals;
  • Overall workforce development to train a new generation of clinical and translational scientists; and
  • Evaluation and accountability with defined criteria for measurement and metrics.

“We are excited to advance the CTSA program by building on its many successes to date,” said Petra Kaufmann, M.D., M.Sc., director of NCATS’ Division of Clinical Innovation. “The evolved CTSAs will better enable the realization of the program’s full potential for transforming clinical and translational science with the ultimate goal of improving human health.”

 

Posted September 2014

Last updated: 08-15-2016
▲ Back to top